πŸ‡ΊπŸ‡Έ FDA
Patent

US 8623828

Blocking mesothelin peptide fragments

granted A61PA61P35/00A61P37/04

Quick answer

US patent 8623828 (Blocking mesothelin peptide fragments) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P35/00, A61P37/04